![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 23, 20999-21006, June 7, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Research Service, Malcom Randall Department of Veterans
Affairs Medical Center and the University of Florida College of
Medicine, Gainesville, Florida 32608, the ¶ Department of
Biochemistry and Molecular Biology, University of Florida College
of Medicine, Gainesville, Florida 32610, the
Received for publication, February 11, 2002, and in revised form, April 2, 2002
An antiparallel actin dimer has been proposed to
be an intermediate species during actin filament nucleation. We now
show that latrunculin A, a marine natural product that inhibits actin polymerization, arrests polylysine-induced nucleation at the level of
an antiparallel dimer, resulting in its accumulation. These dimers,
when composed of pyrene-labeled actin subunits, give rise to a
fluorescent excimer, permitting detection during polymerization in vitro. We report the crystallographic structure of the
polylysine-actin-latrunculin A complex at 3.5-Å resolution. The
non-crystallographic contact is consistent with a dimeric structure and
confirms the antiparallel orientation of its subunits. The
crystallographic contacts reveal that the mobile DNase I binding loop
of one subunit of a symmetry-related antiparallel actin dimer is
partially stabilized in the interface between the two subunits of a
second antiparallel dimer. These results provide a potential
explanation for the paradoxical nucleation of actin filaments that have
exclusively parallel subunits by a dimer containing
antiparallel subunits.
Actin filament nucleation occurs very slowly de novo,
but it occurs rapidly as a necessary step in actin-based motility
(1). The formation of a dimer from monomeric subunits is the
most thermodynamically unfavorable nucleation step with an estimated
equilibrium dissociation constant of 4.6 M (in
contrast to 0.6 mM for conversion of dimer to trimer) in a
recent molecular dynamic simulation of nucleation (2). The formation of
an effective nucleus may be accelerated in vivo by an
actin-binding protein such as gelsolin, which can stabilize dimeric
actin, or by a protein complex such as Arp2/3 that is thought to
contain two actin-like molecules constrained in an orientation that
promotes nucleation (3, 4). Antiparallel actin dimers have been
identified as a precursor to actin filament polymerization by covalent
cross-linking during polymerization induced with divalent cations (5).
A gelsolin-actin complex capable of nucleating filament growth at the
slow growing, pointed end of filaments has also been shown by covalent
cross-linking to contain two actin subunits in the antiparallel
configuration (6). The assumption of an antiparallel configuration of
subunits is based on evidence that Cys-374 in the C terminus of actin
is the only residue involved in the cross-linking reaction. In
contrast, when polymerization is complete, intrafilament cross-linking
yields a parallel dimer. More recently, electron microscopy has
revealed that newly formed actin filaments show evidence of
incorporation of antiparallel dimers. This incorporation results in a
branched filament network, implying that the dimers have nucleating
activity (7). Interestingly, analysis of a Listeria model of
cell motility using high-resolution laser tracking provides evidence
that filaments elongate in 5.4 nm steps, consistent with in
vivo incorporation of dimeric actin (8).
In the current work, we provide evidence that polylysine nucleates
actin polymerization by enhancing the stability of an antiparallel dimer and that the production of antiparallel dimer induced by polylysine and other nucleation-promoting agents correlates well temporally with filament nucleation. We show that the
polylysine-induced dimer accumulates in the presence of latrunculin A,
generating a homogeneous complex that can be crystallized. An x-ray
structure of an antiparallel dimer is reported that correlates well
with the available biochemical data for the solution dimer.
Actin Polymerization and Covalent
Cross-linking--
Polymerization of pyrene-labeled rabbit muscle
actin1 (4% of actin was
labeled except when detecting excimer, in which case 73% was labeled)
was measured at 22 °C using a PTI spectrofluorimeter with excitation
at 366 nm and emission at 387 nm. Actin in buffer G (0.1 mM
CaCl2, 0.2 mM dithiothreitol, 0.2 mM ATP, 0.01% sodium azide, and 5.0 mM Tris,
pH 7.8) was converted to Mg2+-actin by the addition of 125 µM EGTA and 50 µM MgCl2 15 min
prior to the initiation of polymerization. For covalent cross-linking, actin, polylysine, and latrunculin A were mixed at the indicated concentrations. Polylysine (Sigma) with low polydispersity
(weight-average Mr/number-average
Mr is 1.1) had an average of 24 lysine residues. Phenylenedimaleimide (PDM)2
was dissolved in dimethylformamide at 5 mM and diluted
in 10 mM sodium borate, pH 9.2, immediately prior to use.
Cross-linking was initiated by the addition of equal volumes of actin
and PDM to achieve a final molar ratio of either 0.5:1 or 4:1 PDM/actin as previously described (5) so as to optimize the yields of antiparallel or intrafilament dimer, respectively.
Analytical Ultracentrifugation--
Actin, polylysine, and
latrunculin A were mixed at the stated concentrations and centrifuged
in a Beckman XLA analytical ultracentrifuge at 14,400 rpm (for
sedimentation equilibrium) or at 53,000 rpm (for sedimentation
velocity) in buffer G plus 125 µM EGTA, 2 mM MgCl2, and 40 mM KCl. Samples of 110 µl
reached equilibrium in 36 h at 4 °C. Buffer density was 1.0015, and the partial specific volume for the complex was assumed to be that
of actin alone, 0.72 ml/g (9). For sedimentation velocity, 400-µl
samples were loaded into double sector cells at 20 °C. Absorbance
scans were obtained at 12-min intervals at 290 nm. Sedimentation
coefficients were calculated using the second-moment analysis method
(10). Theoretical sedimentation coefficients were calculated using
HYDROPRO (11) using the atomic coordinates of the antiparallel dimer or
of a compact dimer in which two subunits interact via DNase I binding
loop contacts with subdomains 1 and 3 as shown in Fig. 6A.
Crystallization and Data Collection--
Crystals of the
polylysine-actin-latrunculin A-ATP complex were grown at 4 °C from a
solution of equimolar latrunculin A and actin at a concentration of 240 µM with 120 µM polylysine using vapor
diffusion. The crystallization buffer contained 1.3 M
NH4SO4, 1.0 mM ATP, 3.0 mM MgCl2, and 60 mM imidazole, pH
6.7. The crystals were extremely x-ray sensitive, and the x-ray
diffraction data were collected at room temperature to 3.5-Å
resolution using an R-AXIS IV++ system. Attempted collection of
cryogenic data was unsuccessful. A total of 120 diffraction images were
collected from eight actin crystals. Data were indexed using HKL
software (12) with a Rmerge of 0.115. The
diffraction from these crystals is consistent with the orthorhombic
space group P212121, with unit cell
parameters 101.46, 103.03, and 126.96 Å. The crystallographic asymmetric unit contains two actin molecules, which results in a
Matthews coefficient (VM) of 3.95 Å3/Da and
solvent fraction of 70.6%, consistent with our previous report based
on crystal density (13).
Structure Determination and Refinement--
The structure was
determined using molecular replacement (14), using the actin
coordinates taken from the actin-gelsolin segment 1-latrunculin A
structure as the search model (15). The cross-rotation function search
was calculated on a 3° grid with a radius of 40 Å in the 20-3.5 Å resolution range. This search produced a clear solution with the two
highest peaks, 11.74 and 11.06 Actin Filament Nucleation Initiated by an Antiparallel Actin
Dimer--
Actin filament nucleation is fast in vitro when
a short oligomer of polylysine is present (Fig.
1A). The effect of polylysine is very potent relative to molecules such as phalloidin or
jasplakinolide, which promote nucleation by binding at the interface of
three subunits to stabilize a helical actin trimer (Fig.
1B). Given the enhanced intrinsic stability of trimer
relative to dimer, an observed effect greater than that caused by a
very high affinity actin-trimer ligand such as jasplakinolide is likely
related to modulation of actin dimer formation (9). Indeed, if actin is covalently cross-linked during polymerization induced by polylysine, a
substantial yield of antiparallel dimers with high electrophoretic mobility on SDS-PAGE is obtained (Fig.
2A). Consistent with the cross-linking results, polylysine, at saturation, changes the slope of
a log-log plot of the time required to reach 50% completion of
polymerization versus actin concentration from 2.03 for the control data to 1.17. This is most consistent with a change in nucleus
size as defined by Oosawa and Asakura (18) (and also Ref. 19) from four
to two subunits, as might be expected if polylysine enhances the
stability of dimeric actin (Fig. 1B). In contrast, the
potent actin filament stabilizing compound jasplakinolide changed the
slope to 1.56, suggesting a nucleus size of 3, consistent with its
known binding location (9).
The yield of cross-linked antiparallel dimer is substantially higher
when polylysine is used to nucleate polymerization than has been
previously reported for other polymer-inducing conditions (5). If
cross-linking is performed as the polymerization reaction nears
completion then the yield of antiparallel dimer is significantly less,
and the major cross-linked product is then an intrafilament dimer with
lower electrophoretic mobility. (Lane 7 of Fig.
2A shows the depletion of antiparallel dimer with time.)
Both the cross-linking pattern of mature filaments and the normal
appearance of negatively stained polylysine-induced filaments (20)
suggest that polylysine does not alter filament structure. However, if the actin-monomer sequestering drug latrunculin A (13) is added at the
initiation of polymerization, polymerization is arrested at the
dimeric stage, and the antiparallel dimer accumulates (Fig. 2A, lane 6). The cross-linking reaction is not
100% efficient, and therefore monomer is expected to be visible on an
SDS-denatured gel even if the dimer is homogeneous in solution.
Sedimentation equilibrium experiments (performed at 4 °C as
previously described (21) with a mixture of actin, polylysine, and
latrunculin A, at concentrations of 5, 2.5, and 12 µM,
respectively) confirm that actin is homogeneously dimeric (Fig.
2B), even in the presence of high concentrations of divalent
cation (2 mM MgCl2). Results of sedimentation
velocity experiments (data not shown) performed under identical
conditions (except at a temperature of 20 °C) also reveal a
homogeneous species with sedimentation coefficient (s20,w) of 4.81 ± 0.10 S. Because these
results show that the actin is dimeric in solution rather than
filamentous, the antiparallel cross-link cannot be the result of
interfilament cross-linking in a bundle of filaments, as has
been speculated to occur in other conditions (7). Cross-linking and
sedimentation equilibrium experiments in the presence of excess
latrunculin A showed no evidence of dimer formation in the absence of polylysine.
The finding that an antiparallel dimer was an intermediate species
during polylysine-induced actin polymerization was unanticipated. Given
the parallel orientation of subunits in an actin filament, the
antiparallel geometry is paradoxical, with a requisite large change in
subunit orientation if both subunits are incorporated into a filament.
Moreover, in general, conditions that provoke rapid nucleation,
e.g. 2.0 mM MgCl2, have previously
been associated with relatively lower yields of antiparallel dimer (5).
Indeed, because of these considerations, it has been speculated that
the antiparallel dimer could be an inert product of a bimolecular reaction mechanism that is independent of actin polymerization (7). The
evidence that ubiquitous antiparallel dimer formation correlates well
temporally with nucleation events and the evidence of incorporation
during filament polymerization argue that this is not the case (6, 7).
Our new data for polylysine are particularly convincing in this regard,
as the apparent abundance of antiparallel dimer during extremely rapid
polymerization is difficult to reconcile with the idea that the dimer
represents actin diverted to an unpolymerizable state.
For more than 20 years since the discovery of the antiparallel actin
dimer (5, 22) there has been no technique to allow for its detection
other than covalent cross-linking, a procedure requiring extended
incubation times and high pH levels (5). We now find evidence that
pyrene-labeled actin forms an excimer in the antiparallel dimer (and
not in F- or G-actin), providing a "real-time" assay for monitoring
its formation (Fig. 3A).
Because the presence of excimer implies that the pyrene fluorophores
are less than 18 Å apart (23), this is consistent with the biochemical evidence of antiparallel dimer. Of course, this is not proof that antiparallel dimer is present whenever excimer is detected nor proof of
the converse. However, the strong correlation between dimer
formation and conditions/times yielding cross-linking of antiparallel
dimer suggests that these conclusions are reasonable. Polylysine
induces rapid formation of excimer, which decreases in abundance with
time (Fig. 3B). The less potent polycationic nucleating
factor, the phosphorylation site domain of myristoylated alanine-rich
protein kinase C substrate (MARCKS PSD), causes accumulation of excimer
at a slower rate followed by depletion during polymerization (Fig.
3B). Polymerization of Ca2+-actin is accompanied
by the formation of a small amount of excimer during the time interval
that corresponds to filament nucleation (Fig. 3C), providing
the first corroborating evidence of antiparallel dimer formation during
in vitro polymerization of Ca2+-actin.
Crystal Structure of an Antiparallel Actin Dimer--
Dimer
homogeneity in the presence of latrunculin A unexpectedly implied that
polylysine, even though it strongly promoted two-dimensional
polymerization, could be exploited to make crystals of actin.
Successful crystallization conditions were as previously reported for a
complex of latrunculin A and actin (13). The use of polylysine led to
much more rapid crystallization, occurring in as little as a week at
4 °C compared with 3-5 months in the absence of polylysine at this
temperature. These crystals diffracted X-rays to 3.5-Å resolution, and
the structure was determined with refinement of the data to a
crystallographic R-factor of 0.192 and
Rfree of 0.252. Consistent with the biochemical
data shown in Fig. 2, the structure reported here is that of an
antiparallel dimer (Fig. 4). A disulfide
bond can be identified between the Cys-374 residues (Fig.
5). In comparison, previously reported crystallographic structures of actin have either required the presence
of an actin-binding protein that prevents polymerization (24, 25, 26),
or more recently, a covalent modification that renders actin
non-polymerizable (27). These other structures have no demonstrable
non-crystallographic actin-actin interactions indicative of
oligomerization. Crystallographic statistics are summarized in Table
I.
The most extensive crystallographic packing interaction involves the
DNase I binding loop, with a buried interfacial surface area of
2.5 × 103 Å2. The DNase I binding loop
of one subunit of one dimer is sandwiched within a pocket created by
two subunits of a second dimer (Fig. 6A). Within each dimer the
interaction confers stability to only one loop; the other one is
disordered. The ordered loop has a significantly different conformation
compared with prior reported actin structures, indicating extensive
flexibility, as had been previously suggested by both electron
microscopic and crystallographic data (25, 26, 28). The loop is highly
extended with its hydrophobic surface buried within the
non-crystallographic dimer interface (Fig. 6B). The DNase I
binding loop conformation reported here is unlike that recently
described for the crystal structure of a covalently modified form of
ADP-actin that is polymerization incompetent, in which a portion of the
loop is Nucleation of actin polymerization by antiparallel dimer as
reported here has been previously observed qualitatively (7). The
relationship between the crystallographic and solution structures of
antiparallel actin dimer is of interest. The disulfide bond that we
observe in the crystallographic structure very likely does not form
until after crystallization is complete, given that the PDM
cross-linking and analytical ultracentrifugation data prove
definitively that the dimer exists in solution without a disulfide (the
PDM reaction requires a reduced cysteine). The flexibility of the C
terminus reported by others may account for the observation that a
finite length, covalent cross-linking reagent such as PDM (~12 Å separates the reactive maleimide groups) can cross-link antiparallel
dimeric actin in solution, whereas the cysteine residues are fixed in
space at a distance of 6.8 Å (C When latrunculin A was soaked into gelsolin-actin crystals only minor
changes were observed in actin structures involving loops between
residues 55-66 and 197-207 in subdomains II and IV, respectively
(15). Because of the absence of identifiable alterations that fully
explain the inability of actin to polymerize, the authors concluded
that latrunculin A probably acts by interfering with conformational
changes necessary for polymerization. Crystals grown in the
presence of latrunculin A (as reported here) similarly do not reveal
significant changes in actin subunit structure that can be attributed
to latrunculin binding. In the absence of atomic resolution data for
F-actin (and data describing the free energy profile that restricts
dynamic fluctuations in that structure), speculation that any small
conformational change in the actin subunit might prevent polymerization
is not verifiable. The ability of latrunculin A to prevent actin
polymerization (but not antiparallel dimer formation) remains unexplained.
The crystallographic contact reveals a large surface of interaction
between the DNase I binding loop of subdomain 2 and subdomains 1 and 3 of another subunit (subdomain nomenclature is defined in Fig.
4B). This interaction involves the same surface as the site
of longitudinal interaction between subdomain 3 and the DNase I binding
loop that occurs along the long pitch axis of F-actin in the Lorenz
model of the filament, a model based on low resolution diffraction data
from F-actin gels (16, 32). Interestingly, the extended loop in our
crystal structure reveals a much more extensive surface of interaction
than that of the filament model (32). This is significant because a
structure derived from crystals of profilin-actin contains actin-actin
contacts of the DNase I binding loop with subdomain 4 and with the N
terminus, and both contacts are distinct from those of the Lorenz
model. The large surface area of the contacts in the profilin-actin
crystal compared with those of the Lorenz model has led to controversy
regarding the model's validity (26). Normal mode refinements in
F-actin structure support the conclusion that the DNase I binding loop cannot be uniquely oriented given available data (29), but similar to
the crystallographic contact reported here, the refined filament structure includes long pitch axis subunit contacts with subdomain 1 at
residues Ser-350 and Thr-351 (Fig. 6B). These results
suggest that specific features of the crystallographic contact might be incorporated into the current model of F-actin without significant repositioning of the DNase I loop, resulting in more extensive long
pitch helical contact and lower global free energy.
The crystallographic contact between the DNase I binding loop and
subdomains 1 and 3 provides the basis for a hypothesis that explains
the paradox regarding participation of an antiparallel actin dimer in
the helical polymerization of parallel subunits. The extensive surface
of interaction and hydrophobic burial suggests that this contact could
reflect an authentic solution interaction. Because of stabilization of
the mobile DNase I binding loop of a third actin subunit at the
interface between the two subunits of the dimer, the association of a
monomer with antiparallel dimer in this configuration is expected to be
more favorable than the association of two parallel monomers, assuming
otherwise similar binding surfaces. The stability conferred to the
DNase I binding loop by its sandwiched position is apparent in the
electron density map of the dimer in which the non-stabilized loop, in
contrast, is disordered. Because the monomer-antiparallel dimer complex contains parallel-oriented subunits, this provides a mechanism to
augment the association of dimeric subunits with parallel orientation. Although the orientation between parallel subunits in the crystal structure differs significantly from that of existing F-actin models,
flexibility in the DNase I binding loop may permit extensive realignment. Rotation of the DNase I loop-bound subunit by ~90° along the longitudinal axis of the dimer is required to bring two
subunits into an orientation consistent with models of F-actin (Fig.
7). This mechanism does not require that
the crystallographic contact between the DNase I loop and subdomains 3 and 1 be identical to that occurring in F-actin. The flexibility of the
DNase I loop may be sufficient so that any stable tethering of the loop
of one subunit to the antiparallel dimer would increase the effective concentration of reactants and augment the association rate
constant.
Experimental data consistent with a nucleus size of 2-5 actin subunits
have been reported by others (19, 33, 34). Part of this discrepancy can
be explained by differences in the definition of the nucleus (35, 36).
A recent theoretical thermodynamic analysis by Sept and McCammon (2)
did not consider possible conformation transitions between oligomeric
actin structures. In the absence of this consideration, the effective
nucleus size is defined by assumptions implicit in the structural model
of the nucleus, and more specifically, by the number of different types
of actin-actin contacts in the helical oligomer. Given a model (2)
employing two different possible actin-actin intrafilament contacts,
the addition of a fourth subunit to a trimer would represent the same
free energy change as that associated with the addition of another
subunit to a long filament (except for very small differences in change
in entropy as estimated in Ref. 37). Theoretical log-log plots of actin
polymerization (as in Fig. 1B) based on this model would
yield a slope of 2, consistent with the experimental data (2, 36).
However, conformational transitions were introduced by Oosawa and
Asakura (18) as alternative pathways for nucleus assembly for
helical polymers. To the extent that F-actin and G-actin subunit
structures differ, the assumption of some conformational transition
during nucleus formation is a necessity. The conformational transition
implied by the diagram in Fig. 7B, like those introduced by
Oosawa, may alter both the effective size of the nucleus and the
expected dependence of the nucleation rate on the concentration of actin.
Given the results reported here, it is likely that mutations in the C
terminus of actin would result in an aberrant formation of an
antiparallel dimer. The severe nucleation defect in a yeast Cys-374 to
Ser actin mutant (38) and the lethality of a yeast C-terminal-truncated
mutant (39) are therefore consistent with a significant role for the
antiparallel dimer as a filament precursor for in vitro
nucleation and in vivo function. The abnormalities are not
otherwise likely explained by disruption of intrafilament contacts between actin subunits because the Lorenz model shows no
actin-actin contacts at the C terminus (32). Similarly, a filament
model based on the crystallographic interface of profilin-actin crystals will not contain actin-actin contacts involving the C terminus
because profilin occupies that surface (26). Allosteric effects
originating at (or failing to originate at) the C terminus could
provide an alternative explanation for the behavior of these mutants
(31).
Covalently cross-linked intrafilament dimers are excellent nuclei for
seeding actin polymerization (40). However, the formation of dimers
with subunit contacts in the same configuration as intrafilament subunits is thermodynamically unfavorable (2, 19), as might be expected
so as to suppress spontaneous nucleation in vivo and ensure
ordered polymer formation productive for cell motility. With
intrafilament dimer formation intrinsically unlikely, why might the
antiparallel pathway to filament polymerization be useful? The
antiparallel dimer, with its unique configuration, may be more amenable
to specific regulation than a dimer that looks exactly like part of an
actin filament. In fact, actobindin from Acanthamoeba castellanii is a specific inhibitor of nucleation that has been postulated to induce accumulation of a non-helical actin dimer (41,
42). Also, prior data imply that the antiparallel dimer may facilitate
filament branching in conjunction with nucleation (7), which may be
related to the mechanism of Arp2/3-mediated nucleation, either by
accumulation of actin subunits in an antiparallel conformation or by an
antiparallel arrangement of the actin-related subunits in the active
complex. Finally, an antiparallel dimer may participate more
specifically in nucleation than a comparable intrafilament dimer,
which, depending on how it is stabilized by other actin-binding
proteins, might be expected to be as competent for elongation or
capping as for nucleation.
There are several questions associated with the model in Fig. 7.
However, it should be remembered that no alternative explanation for
paradoxical nucleation by antiparallel dimer has been proposed despite
more than 20 years of investigation (22). Most notably, actin-actin
crystallographic contacts may not be predictive of solution
interactions. There is at present no evidence that the DNase I loop
binds to antiparallel dimer in solution as seen in the crystallographic
contact. More generally, there is also no evidence that a third subunit
binds in solution to the dimer, with Fig. 2B showing that
there is no self-association of dimers at concentrations of up to ~10
µM. However, it should be noted that even if the
equilibrium dissociation constant was in the range of 1-3
mM, this mechanism would still be 1000-fold more effective
at creating a linear dimer than through an intrafilament dimer
mechanism (2). There is also the concern that limitations in the range
of mobility of the DNase I binding loop could prevent the
conformational reorganization depicted in Fig. 7B, but this is tempered by the absence of proof that the solution structure of an
actin filament is identical to any of the proposed filament models.
We thank C. Banchs for technical assistance
and J. Richardson for assistance with the artwork.
*
This work was supported by National Institutes of Health NIH
Grant GM53807 (to S. C. A.), the Office of Research and Development, Medical Research Service of the Dept. of Veterans Affairs (to M. R. B.), and the College Incentive Fund of the University of Florida College of Medicine (to R. M. and M. R. B.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1LCU) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
§
To whom correspondence should be addressed: Box 100277, Dept. of
Medicine, University of Florida, Gainesville, FL 32610. Tel.: 352-392-4681; Fax: 352-374-6170; E-mail:
bubbmr@medicine.ufl.edu.
Published, JBC Papers in Press, April 3, 2002, DOI 10.1074/jbc.M201371200
1
Pyrene-labeled actin is defined as actin labeled
on Cys-374 with N-(1-pyrene)iodoacetamide.
The abbreviations used are:
PDM, phenylenedimaleimide;
MARCKS PSD, phosphorylation site domain of
myristoylated alanine-rich protein kinase C substrate;
r.m.s., root
mean square.
Polylysine Induces an Antiparallel Actin Dimer That Nucleates
Filament Assembly
CRYSTAL STRUCTURE AT 3.5-Å RESOLUTION*
§,
,
,
Department of
Biochemistry, Albert Einstein College of Medicine, Bronx, New York
10461, and the ** Institute of Molecular Biophysics,
Florida State University, Tallahassee, Florida 32306
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
, corresponding to two independent
G-actin molecules related by a 2-fold non-crystallographic symmetry
axis. A translation function search with a proposed structure of rabbit
muscle F-actin monomer (16) using the initial rotation function
solutions determined the position of one G-actin as having rotation
angles (
,
, and
) of 12.25, 55.09, and 179.50°; with a
correlation coefficient of 0.395 and an R-factor of 0.462 at
x = 0.105, y = 0.465, and z = 0.006, and the second
G-actin as having rotation angles ((
,
, and
) of 159.15,
85.79, and 100.36°; with a correlation coefficient of 0.362 and an
R-factor of 0.475 at x = 0.848, y = 0.276, and z = 0.273. The F-actin monomer was selected as a starting point for refinement because the crystallization conditions (3 mM
MgCl2) strongly favored conversion of G- to F-actin. A
second translation function search for actin dimer composed of the two
independent actin monomers had a correlation coefficient of 0.680 and
an R-factor of 0.337 at the position x = 0.348, y = 0.276 and z = 0.773. The resulting actin dimer model was refined
using crystallography NMR software version 1.1 (17). Initially, rigid
body refinement was carried out with each monomer defined as an
independent rigid body. Procedures carried out with CNS included
simulated annealing using a maximum likelihood target function,
restrained individual B-factor refinement conjugate gradient
minimization, and bulk solvent correction. The model was refined to a
crystallographic R-factor of 0.192 and
Rfree of 0.252 for all data (50-3.5 Å) (5% of
the data were sequestered before molecular replacement and were used
for calculation of the Rfree value in CNS
refinement). The atomic coordinates and structure factors have been
deposited with the Protein Data Bank.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (25K):
[in a new window]
Fig. 1.
Nucleation of actin polymerization by
polylysine. A, time course of 4% pyrene-labeled rabbit
muscle Mg2+-actin polymerization with polylysine in 40 mM KCl and 2 mM MgCl2. The final
extent of polymerization is similar in all samples. B, a
log-log plot of the time required for actin to become 50% polymerized
as a function of actin concentration in the presence of 5 µM polylysine or 5 µM jasplakinolide. For
data satisfying nucleation-elongation kinetics, a shift to the left
indicates an increase in the rate constant for nucleation, and the
slope of each best fit line is equal to one-half the size of the
nucleus (18).

View larger version (28K):
[in a new window]
Fig. 2.
Accumulation of antiparallel actin dimers
with latrunculin A. A, SDS-polyacrylamide gel
electrophoresis analysis of PDM covalent cross-linking of 3.0 µM Mg2+-actin subunits during the first 12 min of polymerization after addition of 2.0 mM
MgCl2 and polylysine. Cross-linking at 0.5:1 ratio of
PDM/actin is optimal for detection of antiparallel dimer with or
without polylysine (lanes 1 and 2). Cross-linking
at a 4:1 ratio of PDM/actin allows detection of intrafilament dimer
(43) with varying polylysine concentrations (lanes
3-5, respectively). When 8 µM
latrunculin A is added to prevent polymer formation, cross-linking at
0.5:1 ratio of PDM/actin yields only antiparallel dimer with 3.0 µM actin and 1.5 µM polylysine (lane
6). Lane 7 is identical to lane 2 except
actin was polymerized for 60 min prior to cross-linking. B,
sedimentation equilibrium of actin (5 µM) with polylysine
(2.5 µM) and latrunculin A (12 µM) in 2 mM MgCl2 and 40 mM KCl. The
solid line shows the best fit to the data assuming actin is
dimeric, and the dashed line shows the best fit to monomeric
actin. The upper panel shows the distribution of residuals
relative to the theoretical curve for dimeric actin.

View larger version (21K):
[in a new window]
Fig. 3.
Pyrene excimer formation during actin
polymerization. A, emission spectra (excitation at 343 nm) of four samples of 73% pyrene-labeled Mg2+-actin (1 µM) immediately before (curves 1-4) or 20 min
after (curves 5-8) initiation of polymerization by addition
of 2 mM MgCl2. Sample one (spectra 1 and 5) contained no polylysine and no latrunculin A, sample
two (spectra 2 and 6) contained no polylysine and
15 µM latrunculin A, sample three (spectra 3 and 7) contained 5 µM polylysine and no
latrunculin A, and sample four (spectra 4 and 8)
contained 5 µM polylysine and 15 µM
latrunculin A. Inset, expansion of the same spectra between
440 and 550 nm. Spectrum 9 is the difference between
spectra 7 and 8. B, time course of
excimer formation for 1 µM Mg2+-actin in the
presence or absence of 0.5 µM polylysine or 5.0 µM MARCKS PSD was followed at excitation wavelength 343 nm and emission wavelength 478 nm. The time course of polymerization of
the same samples was followed at excitation wavelength 366 nm and
emission wavelength 387 nm. C, time course of polymerization
(circles) and excimer formation (squares) of 10 µM Ca2+-actin after addition of 2 mM CaCl2.

View larger version (27K):
[in a new window]
Fig. 4.
Antiparallel actin dimer. Individual
subunits are colored green and purple in
ribbon-and-strand representation, parallel to the 2-fold
axis (A) and perpendicular to the 2-fold axis
(B). An arrowhead indicates the position
of the ordered DNase I binding loop of subdomain 2 (only observed in
one subunit of the dimer), and an arrow indicates the
disulfide bond between the Cys-374 residues (depicted as
ball-and-stick). Changes in the actin structure compared
with previous reports are limited to the C terminus and subdomain
2. Polylysine is not resolved in the structure. Latrunculin A
occupies a position adjacent to ATP, similar to that described for a
structure of a gelsolin-actin crystal in which latrunculin A had been
soaked into the crystal prior to diffraction data collection
(15).

View larger version (74K):
[in a new window]
Fig. 5.
Close-up view of the dimer interface at the
barbed ends of each of the two subunits. Each monomer contributes
two parallel helices to this interface. A, the four small
helices are stabilized by two intersubunit salt bridges between
residues Glu-361 and Arg-372. B, disulfide bond between the
Cys-374 residues is revealed in a stereo plot of the
2Fo - Fc electron density
contoured at 1.2
and centered on a Cys-374 residue with slab
thickness of 30 Å.
Crystallographic data
-helical (27) and also is different from the compact
structure identified in a complex of profilin and
-actin (26) (Fig.
6C). In contrast, the conformation of this loop is similar
to that for actin subunits in a model of F-actin (29) and, moreover, is
similar to that for profilin-bound actin in the open state, a structure
hypothesized to be the precursor complex that adds to the barbed end of
growing filaments (30). In light of a previous report that <0.1
kcal/mol might be required for the transition between the two most
extreme positions of subdomain 2 shown in Fig. 6C, the full
range of depicted conformations are likely represented in solution
(30). Our results, therefore, suggest that the DNase I binding loop is
likely molded into the observed conformation by its interaction with an
antiparallel actin dimer. Alternatively, dimerization, like many other
binding events at the C terminus of actin (31), may have induced
allosteric changes in the conformation of the DNase I binding loop, but
this is unlikely because both DNase I binding loops are not similarly structured in this otherwise symmetrical antiparallel dimer.

View larger version (23K):
[in a new window]
Fig. 6.
Crystallographic dimer of dimers.
A, backbone trace showing the relative
orientations of crystallographically related dimers (colored as in Fig.
4). Positioning of the DNase I binding loop (arrowhead) of
one subunit of one dimer near the C termini of both subunits of a
second dimer creates a pointed-end-to-barbed-end contact between it and
either subunit of the second dimer. B, close-up view of the
interactions between the DNase I binding loop of subdomain 2 (shown in
gold) with two subunits of a second dimer. The residues
involved include Tyr-143, Gly-146, Thr-148, Glu-167, Gly-168, and
Tyr-169 of subdomain 3 and residues Ala-22, Gly-23, Ile-341, Ile-345,
Leu-349, Ser-350, and Thr-351 of subdomain 1 of one subunit (shown in
purple) in contact with residues Gln-41, Gly-42, Val-43,
Met-44, Val-45, Met-47, Gly-48, Gly-50, Tyr-53, Gly-63, and Ile-64 of
subdomain 2. The other face of the DNase I binding loop is not as
closely associated but contacts the other dimer subunit (shown in
green) at residues Tyr-143, Tyr-166, Glu-167, and Tyr-169 of
subdomain 3 and includes a salt bridge from residue Arg-37 of the DNase
I binding loop to Asp-288 of subdomain 3. C, overlay of
DNase I binding loop and subdomain 2 (residues 28-71) for
profilin-
-actin complex (green; Ref. 26), covalently
modified ADP-actin (blue; Ref. 27), actin-latrunculin A
antiparallel dimer (orange), and profilin-
-actin complex in the open state (red;
Ref. 30). The backbone tracing was generated with Insight II using the
program's global fitting function to superposition the hinge region of
subdomain 2, including
-strands at residues 29-32 and 65-69.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
to C
) by the disulfide bond in
the crystal structure. Similarly, the ability to form a pyrene excimer
implies that the antiparallel dimer can accommodate a bulky fluorescent
probe at the subunit interface. The two salt bridges found in the dimer
interface provide a thermodynamic rationale for the stability of the
dimer in solution in the absence of disulfide, and hydrodynamic data
support the contention that the crystal and solution dimers are of
similar shape. The expected sedimentation coefficient of the
antiparallel actin dimer can be estimated directly from the atomic
coordinates (11), yielding a value of 4.85 S, a result that compares
very well with the experimental value of 4.81 ± 0.10 S. In
contrast to this end-to-end dimer, a compact side-to-side actin dimer
yields a sedimentation coefficient of 5.25 S by the same methodology. Dynamic properties of the antiparallel dimer in solution remain unexamined and add potential complexity to this analysis. In summary, the crystallographic dimer is probably not identical to that occurring in solution (and, in fact, the flexible C-terminal residues may not have a well defined structure in solution), but the evidence strongly supports the following: 1) that both crystallographic and
solution structures are dimeric, 2) that the dimer interface in the
crystal is similar to that present in solution, and 3) that the
sedimentation coefficient is reasonable for a dimer of the shape
predicted by the crystal structure.

View larger version (47K):
[in a new window]
Fig. 7.
Nucleation by antiparallel dimer.
A, illustration depicting dimer of dimers with
one antiparallel actin dimer outlined in red. B,
illustration showing one subunit binding to an antiparallel actin dimer
with the same orientation as in the dimer of dimers. (The ghosted
image of a second subunit is shown only for comparison with
A. The monomer is stabilized by the same crystallographic
contacts as those occurring between antiparallel dimers.) The subunit
then pivots on its DNase I binding loop in the direction of the
blue arrow so as to reach the position shown by the subunit
at the termination of the arrow. C, elongation at
the barbed end of a filament following nucleation by an antiparallel
dimer. As previously observed in samples viewed by electron microscopy
(7), one subunit of the antiparallel dimer is not incorporated into the
filament.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
Supported by the Medical Research Service of the Dept. of Veterans Affairs.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Blanchoin, L.,
Amann, K. J.,
Higgs, H. N.,
Marchand, J. B.,
Kaiser, D. A.,
and Pollard, T. D.
(2000)
Nature
404,
1007-1011[CrossRef][Medline]
[Order article via Infotrieve]
2.
Sept, D.,
and McCammon, J. A.
(2001)
Biophys J.
81,
667-674 3.
Burtnick, L. D.,
Koepf, E. K.,
Grimes, J.,
Jones, E. Y.,
Stuart, D. I.,
McLaughlin, P. J.,
and Robinson, R. C.
(1997)
Cell
90,
661-670[CrossRef][Medline]
[Order article via Infotrieve]
4.
Robinson, R. C.,
Turbedsky, K.,
Kaiser, D. A.,
Marchand, J. B.,
Higgs, H. N.,
Choe, S.,
and Pollard, T. D.
(2001)
Science
294,
1679-1684 5.
Millonig, R.,
Salvo, H.,
and Aebi, U.
(1988)
J. Cell Biol.
106,
785-796 6.
Hesterkamp, T.,
Weeds, A. G.,
and Mannherz, H. G.
(1993)
Eur. J. Biochem.
218,
507-513[Medline]
[Order article via Infotrieve]
7.
Steinmetz, M. O.,
Goldie, K. N.,
and Aebi, U.
(1997)
J. Cell Biol.
138,
559-574 8.
Kuo, S. C.,
and McGrath, J. L.
(2000)
Nature
407,
1026-1029[CrossRef][Medline]
[Order article via Infotrieve]
9.
Bubb, M. R.,
Spector, I.,
Beyer, B. B.,
and Fosen, K. M.
(2000)
J. Biol. Chem.
275,
5163-5170 10.
Schachman, H. K.
(1959)
Ultracentrifugation in Biochemistry
, pp. 75-81, Academic Press, New York
11.
Garcia de la Torre, J.,
Carrasco, B.,
and Harding, S. E.
(1997)
Eur. Biophys. J.
25,
361-372[CrossRef][Medline]
[Order article via Infotrieve]
12.
Otwinowski, Z.,
and Minor, W.
(1997)
Methods Enzymol.
276,
307-326
13.
Yarmola, E. G.,
Somasundaram, T.,
Boring, T. A.,
Spector, I.,
and Bubb, M. R.
(2000)
J. Biol. Chem.
275,
28120-28127 14.
Vagin, A. A.,
and Teplyakov, A.
(2000)
Acta Crystallogr. D. Biol. Crystallogr.
56,
1622-1624[CrossRef][Medline]
[Order article via Infotrieve]
15.
Morton, W. M.,
Ayscough, K. R.,
and McLaughlin, P. J.
(2000)
Nat. Cell Biol.
2,
376-378[CrossRef][Medline]
[Order article via Infotrieve]
16.
Holmes, K. C.,
Popp, D.,
Gebhard, W.,
and Kabsch, W.
(1990)
Nature
347,
44-49[CrossRef][Medline]
[Order article via Infotrieve]
17.
Brünger, A. T.,
Adams, P. D.,
Clore, G. M.,
DeLano, W. L.,
Gros, P.,
Grosse-Kunstleve, R. W.,
Jiang, J. S.,
Kuszewski, J.,
Nilges, M.,
Pannu, N. S.,
Read, R. J.,
Rice, L. M.,
Simonson, T.,
and Warren, G. L.
(1998)
Acta Crystallogr. D. Biol. Crystallogr.
54,
905-921[CrossRef][Medline]
[Order article via Infotrieve]
18.
Oosawa, F.,
and Asakura, S.
(1975)
Thermodynamics of the Polymerization of Protein
, pp. 28-55, Academic Press, New York
19.
Tobacman, L. S.,
and Korn, E. D.
(1983)
J. Biol. Chem.
258,
3207-3214 20.
Brown, S. S.,
and Spudich, J. A.
(1979)
J. Cell Biol.
80,
499-504 21.
Terry, D. R.,
Spector, I.,
Higa, T.,
and Bubb, M. R.
(1997)
J. Biol. Chem.
272,
7841-7845 22.
Mockrin, S. C.,
and Korn, E. D.
(1981)
J. Biol. Chem.
256,
8228-8233 23.
Kim, E.,
and Reisler, E.
(2000)
Biophys. Chem.
86,
191-201[CrossRef][Medline]
[Order article via Infotrieve]
24.
Kabsch, W.,
Mannherz, H. G.,
Suck, D.,
Pai, E. F.,
and Holmes, K. C.
(1990)
Nature
347,
37-44[CrossRef][Medline]
[Order article via Infotrieve]
25.
McLaughlin, P. J.,
Gooch, J. T.,
Mannherz, H. G.,
and Weeds, A. G.
(1993)
Nature
364,
685-692[CrossRef][Medline]
[Order article via Infotrieve]
26.
Schutt, C. E.,
Myslik, J. C.,
Rozycki, M. D.,
Goonesekere, N. C.,
and Lindberg, U.
(1993)
Nature
365,
810-816[CrossRef][Medline]
[Order article via Infotrieve]
27.
Otterbein, L. R.,
Graceffa, P.,
and Dominguez, R.
(2001)
Science
293,
708-711 28.
Orlova, A.,
and Egelman, E. H.
(1993)
J. Mol. Biol.
232,
334-341[CrossRef][Medline]
[Order article via Infotrieve]
29.
Tirion, M. M.,
ben-Avraham, D.,
Lorenz, M.,
and Holmes, K. C.
(1995)
Biophys. J.
68,
5-12 30.
Chik, J. K.,
Lindberg, U.,
and Schutt, C. E.
(1996)
J. Mol. Biol.
263,
607-623[CrossRef][Medline]
[Order article via Infotrieve]
31.
Orlova, A.,
Prochniewicz, E.,
and Egelman, E. H.
(1995)
J. Mol. Biol.
245,
598-607[CrossRef][Medline]
[Order article via Infotrieve]
32.
Lorenz, M.,
Popp, D.,
and Holmes, K. C.
(1993)
J. Mol. Biol.
234,
826-836[CrossRef][Medline]
[Order article via Infotrieve]
33.
Wegner, A.,
and Savko, P.
(1982)
Biochemistry
21,
1909-1913[CrossRef][Medline]
[Order article via Infotrieve]
34.
Cooper, J. A.,
Buhle, E. L. Jr.,
Walker, S. B.,
Tsong, T. Y.,
and Pollard, T. D.
(1983)
Biochemistry
22,
2193-2202[CrossRef][Medline]
[Order article via Infotrieve]
35.
Oosawa, F.,
and Kasai, M.
(1962)
J. Mol. Biol.
4,
10-21[Medline]
[Order article via Infotrieve]
36.
Wegner, A.,
and Engel, J.
(1975)
Biophys. Chem.
3,
215-225[CrossRef][Medline]
[Order article via Infotrieve]
37.
Chatelier, R. C.
(1987)
Biophys. Chem.
28,
121-128[CrossRef][Medline]
[Order article via Infotrieve]
38.
Aspenstrom, P.,
Schutt, C. E.,
Lindberg, U.,
and Karlsson, R.
(1993)
FEBS Lett.
329,
163-170[CrossRef][Medline]
[Order article via Infotrieve]
39.
Johannes, F. J.,
and Gallwitz, D.
(1991)
EMBO J.
10,
3951-3958[Medline]
[Order article via Infotrieve]
40.
Mockrin, S. C.,
and Korn, E. D.
(1983)
J. Biol. Chem.
258,
3215-3232 41.
Bubb, M. R.,
Knutson, J. R.,
Porter, D. K.,
and Korn, E. D.
(1994)
J. Biol. Chem.
269,
25592-25597 42.
Bubb, M. R.,
Lewis, M. S.,
and Korn, E. D.
(1994)
J. Biol. Chem.
269,
25587-25591 43.
Elzinga, M.,
and Phelan, J. J.
(1984)
Proc. Natl. Acad. Sci. U. S. A.
81,
6599-6602
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. Tsuge, M. Nagahama, M. Oda, S. Iwamoto, H. Utsunomiya, V. E. Marquez, N. Katunuma, M. Nishizawa, and J. Sakurai Structural basis of actin recognition and arginine ADP-ribosylation by Clostridium perfringens {iota}-toxin PNAS, May 27, 2008; 105(21): 7399 - 7404. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Reisler and E. H. Egelman Actin Structure and Function: What We Still Do Not Understand J. Biol. Chem., December 14, 2007; 282(50): 36133 - 36137. [Full Text] [PDF] |
||||
![]() |
S. H. Lee, D. B. Hayes, G. Rebowski, I. Tardieux, and R. Dominguez Toxofilin from Toxoplasma gondii forms a ternary complex with an antiparallel actin dimer PNAS, October 9, 2007; 104(41): 16122 - 16127. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Fischer, E. G. Yarmola, K. L. Weber, K. D. Speicher, D. W. Speicher, M. R. Bubb, and V. M. Fowler Tropomodulin 3 Binds to Actin Monomers J. Biol. Chem., November 24, 2006; 281(47): 36454 - 36465. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Pederson and U. Aebi Nuclear Actin Extends, with No Contraction in Sight Mol. Biol. Cell, November 1, 2005; 16(11): 5055 - 5060. [Abstract] [Full Text] [PDF] |
||||